Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert W Leong

Showing results (111-120 of 157) with videos related to

Pageof 16
Sort By:
The American Journal of Gastroenterology|November 2, 2020
The Clinical Relevance of Manometric Esophagogastric Junction Outflow Obstruction Can Be Determined Using Rapid Drink Challenge and Solid SwallowsSantosh Sanagapalli, Joshua McGuire, Rupert W Leong, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitisViraj C Kariyawasam, Fadi H Mourad, Nikola Mitrev, et al.
Journal of Crohn'S & Colitis|January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b StudyWilliam J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Inflammatory Bowel Diseases|May 13, 2017
Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel DiseaseJayson Jeganathan, Cheng Hiang Lee, Antony Rahme, et al.
Emerging Microbes & Infections|April 12, 2018
Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's diseaseFang Liu, Rena Ma, Chin Yen Alfred Tay, et al.
Intestinal Research|May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel diseaseHsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2019
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative ColitisOmoniyi J Adedokun, Zhenhua Xu, Colleen Marano, et al.
Inflammatory Bowel Diseases|November 18, 2021
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling SystemYunki Y Yau, Valerie C Wasinger, Robert P Hirten, et al.
Inflammatory Bowel Diseases|July 4, 2014
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's diseaseViraj C Kariyawasam, Christian P Selinger, Peter H Katelaris, et al.
Journal of Crohn'S & Colitis|March 20, 2020
Knowledge and Attitudes Towards Pregnancy in Females with Inflammatory Bowel Disease: An International, Multi-centre StudyRobyn Laube, Yunki Yau, Christian P Selinger, et al.
Pageof 16

Showing results (111-120 of 157) with videos related to

Sort By:
Pageof 16
The American Journal of Gastroenterology|November 2, 2020
The Clinical Relevance of Manometric Esophagogastric Junction Outflow Obstruction Can Be Determined Using Rapid Drink Challenge and Solid SwallowsSantosh Sanagapalli, Joshua McGuire, Rupert W Leong, et al.
European Journal of Gastroenterology & Hepatology|March 18, 2021
Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitisViraj C Kariyawasam, Fadi H Mourad, Nikola Mitrev, et al.
Journal of Crohn'S & Colitis|January 2, 2016
Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b StudyWilliam J Sandborn, Jean-Frédéric Colombel, Subrata Ghosh, et al.
Inflammatory Bowel Diseases|May 13, 2017
Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel DiseaseJayson Jeganathan, Cheng Hiang Lee, Antony Rahme, et al.
Emerging Microbes & Infections|April 12, 2018
Genomic analysis of oral Campylobacter concisus strains identified a potential bacterial molecular marker associated with active Crohn's diseaseFang Liu, Rena Ma, Chin Yen Alfred Tay, et al.
Intestinal Research|May 19, 2026
Real-world use and perceptions of advanced combined therapies in treating inflammatory bowel diseaseHsin-Yun Wu, Zhi-Che Chen, Meng-Tzu Weng, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 10, 2019
Ustekinumab Pharmacokinetics and Exposure Response in a Phase 3 Randomized Trial of Patients With Ulcerative ColitisOmoniyi J Adedokun, Zhenhua Xu, Colleen Marano, et al.
Inflammatory Bowel Diseases|November 18, 2021
Current Trends in IBD-Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling SystemYunki Y Yau, Valerie C Wasinger, Robert P Hirten, et al.
Inflammatory Bowel Diseases|July 4, 2014
Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's diseaseViraj C Kariyawasam, Christian P Selinger, Peter H Katelaris, et al.
Journal of Crohn'S & Colitis|March 20, 2020
Knowledge and Attitudes Towards Pregnancy in Females with Inflammatory Bowel Disease: An International, Multi-centre StudyRobyn Laube, Yunki Yau, Christian P Selinger, et al.
Pageof 16